Abstract Patients with atopic eczema have significantly higher norepinephrine levels in plasma than healthy controls. In addition, significantly higher levels of the essential cofactor (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin (6BH4) were found in this patient group. Cell extracts from epidermal suction blister roofs revealed only half the normal activity of phenylethanolamine-N-methyl transferase (PNMT) together with a threefold induction of the norepinephrine-degrading enzyme monoamine oxidase A (MAO-A). Taken together, these results support earlier observations of a defective catecholamine/adrenoceptor signal in patients with atopic eczema.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 9 December 1996
Rights and permissions
About this article
Cite this article
Schallreuter, K., Pittelkow, M., Swanson, N. et al. Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289, 663–666 (1997). https://doi.org/10.1007/s004030050258
Issue Date:
DOI: https://doi.org/10.1007/s004030050258